Oil-in-Water Nanosized Emulsions for Drug Delivery and Targeting. Tamilvanan Shunmugaperumal

(2002), Physicochemical screening of antimicrobial agents as potential preservatives for submicron emulsions, Eur. J. Pharm. Sci., 15 (5), 489–495. doi:10.1016/s0928‐0987(02)00034‐9

      85  Tadros, T. (2006), Principles of emulsion stabilization with special reference to polymeric surfactants, J. Cosmet. Sci., 57, 153–169.

      86 Tadros, T., Vandamme, A., Levecke, B. et al. (2004), Stabilization of emulsions using polymeric surfactants based on inulin, Adv. Colloid Interf. Sci., 108–109, 207–226. doi:10.1016/j.cis.2003.10.024

      87 Tambe, D.E. and Sharma, M.M. (1993), Factors controlling the stability of colloid‐stabilized emulsions: I. an experimental investigation, J. Colloid Interface Sci., 157, 244–253. doi:10.1006/jcis.1993.1182

      88 Tamilvanan, S. (2004), Oil‐in‐water lipid emulsions: implications for parenteral and ocular delivering systems, Prog. Lipid Res., 43 (6), 489–533. doi:10.1016/j.plipres.2004.09.001

      89 Tamilvanan, S. (2008), Oil‐in‐water nanosized emulsions: medical applications, in: Gad, S.C., Ed., Pharmaceutical Manufacturing Handbook, Chapter 7.4, John Wiley & Sons Publishers, Hoboken, NJ, pp. 1329–1368. doi:10.1002/9780470259818.ch34

      90 Tamilvanan, S. (2009), Formulation of multifunctional oil‐in‐water nanosized emulsions for active and passive targeting of drugs to otherwise inaccessible internal organs of the human body, Int. J. Pharm., 381 (1), 62–76. doi:10.1016/j.ijpharm.2009.08.001

      91 Tamilvanan, S. and Benita, S. (2004), The potential of lipid emulsion for ocular delivery of lipophilic drugs, Eur. J. Pharm. Biopharm., 58 (2), 357–368. doi:10.1016/j.ejpb.2004.03.033

      92 Tamilvanan, S., Khoury, K., Gilhar, D. et al. (2001), Ocular delivery of cyclosporin A. I. Design and characterization of cyclosporin A‐loaded positively‐charged submicron emulsion, STP Pharma Sci., 11, 421–426.

      93 Tamilvanan, S., Kumar, B., Senthilkumar, S.R. et al. (2010), Stability assessment of injectable castor oil‐based nanosized emulsion containing cationic droplets stabilized by poloxamer‐chitosan emulsifier films, AAPS PharmSciTech., 11 (2), 904–909. doi:10.1208/s12249‐010‐9455‐3

      94 Tamilvanan, S., Schmidt, S., Müller, R.H. et al. (2005), In vitro adsorption of plasma proteins onto the surface (charges) modified‐submicron emulsions for intravenous administration, Eur. J. Pharm. Biopharm., 59 (1), 1–7. doi:10.1016/j.ejpb.2004.07.001

      95 Tang, S.Y., Manickam, S., Wei, T.K. et al. (2012), Formulation development and optimization of a novel cremophor EL‐based nanoemulsion using ultrasound cavitation, Ultrason. Sonochem., 19 (2), 330–345. doi:10.1016/j.ultsonch.2011.07.001

      96 Teixeira, H., Dubernet, C., Puisieux, F. et al. (1999), Submicron cationic emulsions as a new delivery system for oligonucleotides, Pharm. Res., 16, 30–36. doi:10.1023/A:1018806425667

      97 Trotta, M., Pattarino, F., and Ignoni, T. (2002), Stability of drug‐carrier emulsions containing phosphatidylcholine mixtures, Eur. J. Pharm. Biopharm., 53 (2), 203–208. doi:10.1016/s0939‐6411(01)00230‐2

      98 Velev, O.D., Furusawa, K., and Nagayama, K. (1996), Assembly of latex particles by using emulsion droplets as templates. 1. Microstructured hollow spheres, Langmuir, 12, 2374–2384. doi:10.1021/la9506786

      99 Weiss, C.K., Lorenz, M.R., Landfester, K. et al. (2007), Cellular uptake behavior of unfunctionalized and functionalized PBCA particles prepared in a miniemulsion, Macromol. Biosci., 7, 883–896. doi:10.1002/mabi.200700046

      100 Woitiski, C.M. Veiga, F. Ribiero, A. et al. (2009), Design for optimization of nanoparticles integrating biomaterials for orally dose insulin, Eur. J. Pharm. Biopharm., 73 (1), 25–33. doi:10.1016/j.ejpb.2009.06.002

      101  Yaseen, M., Lu, J.R., Webster, J.R.P. et al. (2006), The structure of zwitterionic phosphocholine surfactant monolayers, Langmuir, 22, 5825–5832. doi:10.1021/la053316z

      102 Yi, S.W., Yune, Y., Kim, T.W. et al. (2000), A cationic lipid emulsion/DNA complex as a physically stable and serum‐resistant gene delivery system, Pharm. Res., 17, 314–320. doi:10.1023/A:1007553106681

      103 Yilmaz, H. and Borchert, H.H. (2005), Design of a phytosphingosine‐containing, positively charged nanoemulsion as a colloidal carrier system for dermal application of ceramides, Eur. J. Pharm. Biopharm., 60, 91–98. doi:10.1016/j.ejpb.2004.11.009

      104 Yu, L.X. (2008), Pharmaceutical quality by design: product and process development, understanding, and control, Pharm. Res., 25 (4), 781–791. doi:10.1007/s11095‐007‐9511‐1

      105 Yu, L.X., Amidon, G., Khan, M.A. et al. (2014), Understanding pharmaceutical quality by design, AAPS J., 16 (4), 771–781. doi:10.1208/s12248‐014‐9598‐3

      Note

      1 * The funding provided by Department of Biotechnology, Govt. of India to Syed Nazrin Ruhina Rahman is greatly acknowledged.